1.
SB431542-Loaded Liposomes Alleviate Liver Fibrosis by Suppressing TGF-ß Signaling.
Mol Pharm
; 17(11): 4152-4162, 2020 11 02.
Article
En
| MEDLINE | ID: mdl-33089693
2.
CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
Acta Biomater
; 168: 484-496, 2023 09 15.
Article
En
| MEDLINE | ID: mdl-37392933
3.
Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity.
J Control Release
; 320: 32-44, 2020 04 10.
Article
En
| MEDLINE | ID: mdl-31931051
4.
An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis.
J Control Release
; 303: 77-90, 2019 06 10.
Article
En
| MEDLINE | ID: mdl-31004666